SAMHD1 downregulation has also been linked to protection of cancer development in patients [6,47,48] casting doubt on the role of SAMHD1 as a tumor suppressor and highlighting the need of further evaluating its clinical significance in different tumor types. The gene discussed is SAMHD1; the disease is neoplasm.